Publication:
Carboplatin-based regimen in pediatric intracranial germ-cell tumors (IC-GCTs): Effectiveness and ototoxicity

dc.contributor.authorRasin Worawongsakulen_US
dc.contributor.authorNongnuch Sirachainanen_US
dc.contributor.authorApimid Rojanawatsirivejen_US
dc.contributor.authorAtthaporn Boongirden_US
dc.contributor.authorArunee Singhsnaehen_US
dc.contributor.authorThiti Swangsilpaen_US
dc.contributor.authorMantana Dhanachaien_US
dc.contributor.authorPutipun Puataweepongen_US
dc.contributor.authorRawee Ruangkanchanasetren_US
dc.contributor.authorSamart Pakakasamaen_US
dc.contributor.authorUsanarat Anurathapanen_US
dc.contributor.authorDuantida Songdejen_US
dc.contributor.authorPongpak Pongphitchaen_US
dc.contributor.authorChaiyos Khongkhatithumen_US
dc.contributor.authorAke Hansasutaen_US
dc.contributor.authorNintita Sripaiboonkij Thokaniten_US
dc.contributor.authorApasri Lusawaten_US
dc.contributor.authorSarunya Yuthagoviten_US
dc.contributor.authorSamasuk Thammachanthaen_US
dc.contributor.authorDanupon Muangruken_US
dc.contributor.authorSuradej Hongengen_US
dc.contributor.otherFaculty of Medicine, Ramathibodi Hospital, Mahidol Universityen_US
dc.contributor.otherPrasat Neurological Instituteen_US
dc.contributor.otherLoei Hospitalen_US
dc.date.accessioned2020-06-02T05:03:24Z
dc.date.available2020-06-02T05:03:24Z
dc.date.issued2020-03-19en_US
dc.description.abstract© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. Background: Induction chemotherapy with carboplatin followed by radiotherapy has been used for many years for treating intracranial germ-cell tumors (IC-GCTs) in Thailand. The objective of this study was to assess treatment outcomes, focusing on survival and ototoxicity. Methods: The outcomes of all patients with IC-GCT treated at Ramathibodi Hospital and the Prasat Neurological Institute between 2000 and 2017 were reviewed and analyzed, including all patient characteristics and treatment modalities. Five-year overall survival (OS) and event-free survival (EFS) were analyzed using the Kaplan-Meier method, and factors affecting survival were compared using the log-rank test. Results: Fifty-three patients age 1-14 years (median, 11 years) were included in this study. The median follow-up time was 63 months. The 5-year EFS and OS rates were 94.3% and 96.2% for all patients, respectively. No statistical difference in OS or EFS was observed between the data of recipients in the carboplatin-based and historical cisplatin-based therapies in our institutes. Concerning radiotherapy, omission of radiotherapy or focal irradiation results in worse long-term survival outcomes, but reduction in dose of radiotherapy to less than 40 Gy did not cause any negative impact on survival rates. Furthermore, carboplatin was associated with lower rates of hearing loss than cisplatin (5.7% vs 87.5%). Conclusions: Induction chemotherapy with carboplatin-based regimens was associated with excellent survival rates and low ototoxicity in patients with IC-GCT. Radiotherapy should be given to all patients with a minimal volume equivalent to whole-ventricular radiotherapy, during which doses of lower than 40 Gy can be effectively used.en_US
dc.identifier.citationNeuro-Oncology Practice. Vol.7, No.2 (2020), 202-210en_US
dc.identifier.doi10.1093/nop/npz043en_US
dc.identifier.issn20542585en_US
dc.identifier.issn20542577en_US
dc.identifier.other2-s2.0-85084003815en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/56278
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084003815&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleCarboplatin-based regimen in pediatric intracranial germ-cell tumors (IC-GCTs): Effectiveness and ototoxicityen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85084003815&origin=inwarden_US

Files

Collections